$RKDA·4

Arcadia Biosciences, Inc. · May 25, 7:14 PM ET

Arcadia Biosciences, Inc. 4

4 · Arcadia Biosciences, Inc. · Filed May 25, 2016

Insider Transaction Report

Form 4
Period: 2016-05-23
KETKAR RAJENDRA D.
Chief Executive Officer
Transactions
  • Award

    Stock Option (right to buy)

    2016-05-23+225,000225,000 total
    Exercise: $6.00Exp: 2026-05-22Common Stock (225,000 underlying)
  • Award

    Stock Option (right to buy)

    2016-05-23+225,000225,000 total
    Exercise: $8.00Exp: 2026-05-22Common Stock (225,000 underlying)
  • Award

    Stock Option (right to buy)

    2016-05-23+50,00050,000 total
    Exercise: $12.00Exp: 2026-05-22Common Stock (50,000 underlying)
  • Award

    Stock Option (right to buy)

    2016-05-23+50,00050,000 total
    Exercise: $15.00Exp: 2026-05-22Common Stock (50,000 underlying)
  • Award

    Stock Option (right to buy)

    2016-05-23+200,000200,000 total
    Exercise: $1.35Exp: 2026-05-22Common Stock (200,000 underlying)
Footnotes (1)
  • [F1]The option vests with respect to 25% of the total securities subject to the option on the first anniversary of the date of award, or May 23, 2017, with the remaining 75% vesting in 36 equal installments beginning May 31, 2017 and ending April 30, 2020.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION